READ: ARW ON CGT

GettyImages-1768059831 ARW’s CGT+RNA Manufacturing Must-Reads (‘TWAS THE NIGHT BEFORE CHRISTMAS’ EDITION!)

Day-in and day-out, I write, read, listen to, and watch as much content as I can about CGT and RNA therapy manufacturing, in particular, and/or other ATMP industry-related topics that you should at least be aware of in the manufacturing facility. Every two weeks, I compile the articles and industry updates I think are most worthy of your time into an unconventional newsletter format (below) and send them out via email.

  • “With This MSA, I Thee Contract:” The “Make-or-Breaks” In CGT Outsourcing Negotiations

    To help us all feel a bit stronger in the face of a negotiation, Haskett and Graskemper did not shy away from providing their go-to contracting best practices and tips for tackling an MSA and Quality Technical Agreement (QTA). While our discussion was far from exhaustive, they singled out several potentially showstopping areas that demand greater prescriptiveness in our MSAs for the sake of much stronger and long-term outsourcing partnerships. 

WATCH: ARW ON RNA

ARWonRNA_Ep05_FlyFishing_Thumbnail Fly Fishing Meets mRNA | ARW On RNA Ep05

Hosted by Cell & Gene Collaborative Director Anna Rose Welch, ARW on RNA puts a creative spin on the emerging mRNA + RNA therapeutics industry. Here, in Episode 5, Welch dives into the separate — but strikingly similar — worlds of fly fishing and mRNA R&D. In particular, she explains how a fly fisherman’s strategies to catch a fish relate to the work of mRNA scientists as they strive to identify the most appropriate immunogenicity profiles for their mRNA vaccines or therapeutics.    

  • Harry Potter Meets mRNA | ARW On RNA Ep01

    Hosted by Cell & Gene Collaborative's Director Anna Rose Welch, ARW on RNA puts a creative spin on the emerging mRNA + RNA therapeutics industry. Here, in Episode 1, Welch draws a few connections between the magical world of Harry Potter and the challenging scientific work mRNA companies are doing today to explore and/or broaden mRNA's therapeutic potential in a variety of indications.

ABOUT CELL & GENE COLLABORATIVE

We are an editorial resource and virtual peer-group bringing together the best and brightest manufacturing minds in the advanced therapies industry. We cue the conversations and provide an off-the-beaten path forum for manufacturing professionals to meet their peers and learn from each other — and have a great time doing it.

MEET ARW

Anna RoseAnna Rose Welch is the director of Cell & Gene Collaborative. In this role, she is forging close relationships with the leading voices and organizations in the cell and gene therapy manufacturing sphere. This includes establishing a peer group comprising Cell & Gene company manufacturing SMEs, conducting interviews and hosting interactive roundtables on the evolving manufacturing paradigm, and authoring thought leadership articles and blog posts via the Cell & Gene Collaborative blog.